ATE412759T1 - Loxp sequenz-varianten und deren verwendung - Google Patents

Loxp sequenz-varianten und deren verwendung

Info

Publication number
ATE412759T1
ATE412759T1 AT98953027T AT98953027T ATE412759T1 AT E412759 T1 ATE412759 T1 AT E412759T1 AT 98953027 T AT98953027 T AT 98953027T AT 98953027 T AT98953027 T AT 98953027T AT E412759 T1 ATE412759 T1 AT E412759T1
Authority
AT
Austria
Prior art keywords
bases
loxp site
wild
image
specific recombination
Prior art date
Application number
AT98953027T
Other languages
English (en)
Inventor
Izumu Saito
Keiji Tanaka
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE412759T1 publication Critical patent/ATE412759T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT98953027T 1997-11-13 1998-11-12 Loxp sequenz-varianten und deren verwendung ATE412759T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33128997 1997-11-13
JP27315098A JP4206154B2 (ja) 1997-11-13 1998-09-28 変異型loxP配列とその応用

Publications (1)

Publication Number Publication Date
ATE412759T1 true ATE412759T1 (de) 2008-11-15

Family

ID=26550537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953027T ATE412759T1 (de) 1997-11-13 1998-11-12 Loxp sequenz-varianten und deren verwendung

Country Status (12)

Country Link
US (1) US6465254B1 (de)
EP (1) EP1035208B1 (de)
JP (1) JP4206154B2 (de)
KR (1) KR100639088B1 (de)
CN (1) CN1173039C (de)
AT (1) ATE412759T1 (de)
AU (1) AU741415B2 (de)
CA (1) CA2309386C (de)
DE (1) DE69840173D1 (de)
DK (1) DK1035208T3 (de)
NZ (1) NZ504307A (de)
WO (1) WO1999025851A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
EP2322614A1 (de) 1995-06-07 2011-05-18 Life Technologies Corporation Rekombinatorische Klonierung unter Verwendung genmanipulierter Rekombinationsorte
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
EP1025217B1 (de) 1997-10-24 2006-10-04 Invitrogen Corporation Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
JP4153607B2 (ja) 1998-11-18 2008-09-24 大日本住友製薬株式会社 新規な組換えアデノウイルス
EP1173460B1 (de) 1999-03-02 2009-09-16 Life Technologies Corporation Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
AU6529900A (en) * 1999-08-09 2001-03-05 Monsanto Technology Llc Novel cloning methods and vectors
NZ539430A (en) 1999-12-10 2006-09-29 Invitrogen Corp Use of multiple recombination sites with unique specificity in recombinational cloning
JP2001321174A (ja) * 2000-05-11 2001-11-20 Japan Science & Technology Corp アンチセンス型ジーントラップベクター
US7244560B2 (en) 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
EP1322152A2 (de) * 2000-10-03 2003-07-02 ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire Transgene maus zur gezielten rekombination vermittelt durch verändertes cre-er
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
WO2002083889A2 (en) * 2001-04-10 2002-10-24 Imperial College Innovations Limited Methods for the production of minicircles
WO2003025161A1 (en) * 2001-09-18 2003-03-27 Clontech Laboratories, Inc. Site-specific recombinase based method for producing adenoviral vectors
ATE384129T1 (de) 2001-11-22 2008-02-15 Univ Keio Künstliche antikörperbibliothek mit super- repertoire
US6818420B2 (en) 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
IL164687A0 (en) 2002-05-02 2005-12-18 Univ North Carolina Cellular libraries and methods for the preparationthereof
WO2004020605A2 (en) 2002-08-29 2004-03-11 The Board Of Trustees Of The Leland Stanford Junior University Circular nucleic acid vectors, and methods for making and using the same
US20040216178A1 (en) * 2003-03-03 2004-10-28 Jones Stephen N Regulation of mdm2 function
US20060024681A1 (en) * 2003-10-31 2006-02-02 Agencourt Bioscience Corporation Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
EP1751180A4 (de) * 2004-02-26 2012-01-04 Israel State Enzyme, zellen und verfahren zur stellenspezifischen rekombination an asymmetrischen stellen
JP2006333742A (ja) * 2005-05-31 2006-12-14 Chemicals Evaluation & Research Institute 細胞及び細胞へのdna導入方法
ES2390132T3 (es) * 2005-07-18 2012-11-06 Pioneer Hi-Bred International Inc. Sitios de recombinación FRT modificados y métodos de uso
WO2007110695A2 (en) * 2005-10-13 2007-10-04 Bc Cancer Agency Modular genomes for synthetic biology and metabolic engineering
US20070143881A1 (en) * 2005-12-16 2007-06-21 Pioneer Hi-Bred International, Inc. Methods and Compositions for Improving the Efficiency of Site-Specific Polynucleotide Exchange
WO2007134122A2 (en) 2006-05-09 2007-11-22 The Curators Of The University Of Missouri Plant artificial chromosome platforms via telomere truncation
US20070271629A1 (en) 2006-05-17 2007-11-22 Pioneer Hi-Bred International, Inc. Artificial plant minichromosomes
EP2167666A2 (de) 2007-06-29 2010-03-31 Pioneer Hi-Bred International Inc. Verfahren zur veränderung des genoms einer monokotyledonen-zelle
EP2067858A1 (de) 2007-12-07 2009-06-10 Universidad de Sevilla Tiermodelle für neurodegenerative Erkrankungen
WO2012044847A1 (en) 2010-10-01 2012-04-05 Life Technologies Corporation Nucleic acid adaptors and uses thereof
JP2011509095A (ja) 2008-01-09 2011-03-24 ライフ テクノロジーズ コーポレーション 核酸配列決定のための対をなすタグのライブラリーを製造する方法
ES2337973B8 (es) 2008-05-16 2011-07-21 Proyecto De Biomedicina Cima, S.L. Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
WO2011082310A2 (en) 2009-12-30 2011-07-07 Pioneer Hi-Bred International, Inc. Methods and compositions for targeted polynucleotide modification
CA2831144A1 (en) 2011-03-23 2012-09-27 Pioneer Hi-Bred International, Inc. Methods for producing a complex transgenic trait locus
AU2012249390B2 (en) 2011-04-27 2017-03-30 Amyris, Inc. Methods for genomic modification
CA2844470A1 (en) 2011-06-21 2013-05-10 Pioneer Hi-Bred International, Inc. Methods and compositions for producing male sterile plants
US9657309B2 (en) * 2012-03-12 2017-05-23 Dsm Ip Assets B.V. Recombination system
CN103361342B (zh) * 2012-03-30 2019-01-25 上海杰隆生物工程股份有限公司 一种转基因定位整合的方法及其应用
US20140173775A1 (en) 2012-12-13 2014-06-19 Pioneer Hi-Bred International, Inc. Methods and compositions for producing and selecting transgenic plants
ES2523016B1 (es) 2013-05-20 2015-09-09 3P Biopharmaceuticals Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
EP3083958B1 (de) 2013-12-19 2019-04-17 Amyris, Inc. Verfahren zur genomischen integration
WO2016077457A1 (en) 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
CN105316362B (zh) * 2015-08-19 2020-03-17 暨南大学 一种Dual-RMCE介导的TCR基因置换系统及其方法
DK3341483T3 (da) 2015-08-28 2020-03-16 Pioneer Hi Bred Int Ochrobactrum-medieret transformation af planter
US11293033B2 (en) 2016-05-18 2022-04-05 Amyris, Inc. Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
KR20220034848A (ko) 2019-07-11 2022-03-18 클라라 푸드즈 컴퍼니 단백질 조성물 및 이의 섭취 가능한 제품
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
JP2024530215A (ja) * 2021-08-13 2024-08-16 上海▲シン▼湾生物科技有限公司 低酸素トリガーの人工転写因子、転写制御システム及びその応用
CN118475700A (zh) 2021-12-27 2024-08-09 礼富利科技股份有限公司 温度敏感性的负链rna病毒或病毒载体及其rna基因组
CN117165627A (zh) * 2022-05-27 2023-12-05 上海科技大学 基于Cre-LoxP和CRISPR的核酸构建体及其应用
WO2024195811A1 (ja) 2023-03-22 2024-09-26 株式会社レプリテック 温度感受性のマイナス鎖rnaウイルスまたはウイルスベクターおよびそのrnaゲノム
CN118147146B (zh) * 2024-03-25 2024-09-17 中国科学院水生生物研究所 突变型LoxP元件、其表达载体和在鱼类基因工程育种中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2319497A (en) * 1996-03-07 1997-09-22 Regents Of The University Of California, The Helper-free, totally defective adenovirus for gene therapy
US6271436B1 (en) * 1996-10-11 2001-08-07 The Texas A & M University System Cells and methods for the generation of transgenic pigs

Also Published As

Publication number Publication date
US6465254B1 (en) 2002-10-15
NZ504307A (en) 2001-07-27
JPH11196880A (ja) 1999-07-27
EP1035208A4 (de) 2002-01-30
KR20010032020A (ko) 2001-04-16
CA2309386A1 (en) 1999-05-27
EP1035208B1 (de) 2008-10-29
AU1052699A (en) 1999-06-07
KR100639088B1 (ko) 2006-10-27
DE69840173D1 (de) 2008-12-11
CN1173039C (zh) 2004-10-27
CN1283233A (zh) 2001-02-07
CA2309386C (en) 2010-07-13
WO1999025851A1 (en) 1999-05-27
JP4206154B2 (ja) 2009-01-07
AU741415B2 (en) 2001-11-29
EP1035208A1 (de) 2000-09-13
DK1035208T3 (da) 2009-02-23

Similar Documents

Publication Publication Date Title
ATE412759T1 (de) Loxp sequenz-varianten und deren verwendung
JPH11196880A5 (de)
DK1167542T3 (da) Probe til diagnosticering af infektionssygdom, der opstår fra Enterococcus faecalis
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
IT1270882B (it) Oligopeptidi ad attivita' fungicida
ATE253063T1 (de) 5-ht1f-agonisten
PT1132403E (pt) Peptidos inibidores de tgf g beta1
EP1108058A4 (de) Evolution ganzer zellen und organismen durch rekursive sequenz-rekombination
CY1106114T1 (el) Παραγωγα τροπανιου σαν ρυθμιστες ccr5
ATE442436T1 (de) Mutationen im myostatingen steigern muskelmasse in säugetieren
DK1471926T3 (da) Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
ATE448309T1 (de) Luziferase expressionskassetten und methoden zu ihrer verwendung
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
EP1201759A4 (de) "gen-fallen-vektor" und verfahren zum "einfangen" von genen mittels dieses vektors
NO20002408D0 (no) 5-HT1F antagonister
ATE348158T1 (de) Neuartiges collectin
AU4454196A (en) Substituted phenyl compounds as endothelin antagonists
DK0708088T3 (da) Alkyl-5-methylsulfonyl-benzoyl-guanidinderivater
ATE381260T1 (de) Transgene hergestellte antithrombin iii und deren mutanten
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
EP1065269A4 (de) Für hm1.24 antigen kodierendes gen und dessen promotor
DE60329931D1 (de) Fprl1-liganden und deren verwendung
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40
ATE266626T1 (de) Fluorierung von ketoamiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties